Intuitive customers are showing increased interest in cardiac surgery, and it's invested in robotic heart surgery startup ...

A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the ...

Tenaya Therapeutics, Inc.’s TNYA share price has dipped by 11.06%, which has investors questioning if this is right time to buy.

Verve Therapeutics, Inc.’s VERV share price has dipped by 11.69%, which has investors questioning if this is right time to buy.

Verve received FDA IND clearance for VERVE-102 to treat HeFH, adding new trial sites in the United States. Read more about ...

Incorrect wall and David Raya’s poor positioning: The free-kick that caught out Arsenal Portuguese’s controversial free-kick appeared to be aided by both the unusual positioning of the wall ...

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm thinks the challenges to owning United in 2025 are ...

Serina Therapeutics Background Information (This description ... targeting human aging and degenerative diseases in the united states. the company's lead cell-based therapeutic candidates in ...

Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) – Equities research analysts at Wedbush raised their Q1 2025 earnings per share (EPS) estimates for Fate Therapeutics in a research note ...

(CNN) — Manchester United may be experiencing one of the most chastening seasons in its recent history, but the club is planning for a much brighter future. On Tuesday, the 13-time Premier ...

March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...